Literature DB >> 12000113

Mu opioid receptors are in discrete hippocampal interneuron subpopulations.

Carrie T Drake1, Teresa A Milner.   

Abstract

In the rat hippocampal formation, application of mu opioid receptor (MOR) agonists disinhibits principal cells, promoting excitation-dependent processes such as epileptogenesis and long-term potentiation. However, the precise location of MORs in particular inhibitory circuits, has not been determined, and the roles of MORs in endogenous functioning are unclear. To address these issues, the distribution of MOR-like immunoreactivity (-li) was examined in several populations of inhibitory hippocampal neurons in the CA1 region using light and electron microscopy. We found that MOR-li was present in many parvalbumin-containing basket cells, but absent from cholecystokinin-labeled basket cells. MOR-li was also commonly in interneurons containing somatostatin-li or neuropeptide Y-li that resembled the "oriens-lacunosum-moleculare" (O-LM) interneurons innervating pyramidal cell distal dendrites. Finally, MOR-li was in some vasoactive intestinal peptide- or calretinin-containing profiles resembling interneurons that primarily innervate other interneurons. These findings indicate that MOR-containing neurons form a neurochemically and functionally heterogeneous subset of hippocampal GABAergic neurons. MORs are most frequently on interneurons that are specialized to inhibit pyramidal cells, and are on a limited number of interneurons that target other interneurons. Moreover, the distribution of MORs to different neuronal types in several laminae, some relatively far from endogenous opioids, suggests normal functional roles that are different from the actions seen with exogenous agonists such as morphine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000113     DOI: 10.1002/hipo.1107

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  60 in total

1.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores.

Authors:  Ai-Hui Tang; Miranda A Karson; Daniel A Nagode; J Michael McIntosh; Victor N Uebele; John J Renger; Matthias Klugmann; Teresa A Milner; Bradley E Alger
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

3.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

4.  Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

5.  Complementary modulation of somatic inhibition by opioids and cannabinoids.

Authors:  Lindsey L Glickfeld; Bassam V Atallah; Massimo Scanziani
Journal:  J Neurosci       Date:  2008-02-20       Impact factor: 6.167

Review 6.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

7.  Mu-Opioids Suppress GABAergic Synaptic Transmission onto Orbitofrontal Cortex Pyramidal Neurons with Subregional Selectivity.

Authors:  Benjamin K Lau; Brittany P Ambrose; Catherine S Thomas; Min Qiao; Stephanie L Borgland
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

8.  Cortical opioid markers in schizophrenia and across postnatal development.

Authors:  David W Volk; Polina V Radchenkova; Erin M Walker; Elizabeth J Sengupta; David A Lewis
Journal:  Cereb Cortex       Date:  2011-08-01       Impact factor: 5.357

9.  Ivy and neurogliaform interneurons are a major target of μ-opioid receptor modulation.

Authors:  Esther Krook-Magnuson; Lillian Luu; Sang-Hun Lee; Csaba Varga; Ivan Soltesz
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

10.  Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  M J Glass; L Vanyo; L Quimson; V M Pickel
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.